Cipla recalls 7,228 bottles of Solifenacin Succinate tablets

26 Jul 2021 Evaluate

Cipla is recalling 7,228 bottles of Solifenacin Succinate tablets, a medicine used to treat overactive bladder, in the US market due to manufacturing issues. The company is recalling 10 mg, 30-count bottles in the US. The company has initiated the recall on June 10 this year and the USFDA has classified it as a Class II recall.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1329.75 1.50 (0.11%)
29-Jan-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.35
Dr. Reddys Lab 1216.00
Cipla 1329.75
Zydus Lifesciences 891.65
Lupin 2129.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×